In our previous study [16], the differences in the median activation of pSTAT1 between melanoma patients and healthy controls were 1.6 fold were as, in the current study, the median differences in STAT1 activation between the responders and non-responders were 1.4 fold. The gene discussed is STAT1; the disease is melanoma.